Ectopic pregnancy and miscarriage: diagnosis and initial management (update)

You can now review and comment on this draft guideline.

As part of the guideline update, we are also revising NICE’s quality standard on ectopic pregnancy and miscarriage (QS69). We propose adding a new quality statement which covers the use of anti‑D immunoglobulin prophylaxis. This new statement can be found in the Draft guideline.

We invite you to also provide feedback on this draft quality statement as part of this guideline consultation. Comments on the draft quality statement should be submitted using the same form as for comments on the guideline consultation.

The consultation closes on Tuesday 17^th February at 5pm.

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline
• Evidence review E - Anti-D immunoglobulin prophylaxis
• Equality and health inequalities assessment 4
• Supporting documentation – Appendices for evidence review E
• Supporting documentation – Acknowledgements

Other information about the consultation

• Committee membership list
• Developing NICE guidelines: how to get involved
• Final scope – for information

3. Add your comments

• You must use this comments form
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges
• Developing NICE guidelines: how to get involved suggests some other areas to comment on.
• As part of the guideline update, we are also revising NICE’s quality standard on ectopic pregnancy and miscarriage (QS69). We propose adding a new quality statement which covers the use of anti‑D immunoglobulin prophylaxis. We invite you to also provide feedback on this draft quality statement as part of this guideline consultation.

4. Email the form to us

Email: Ectopic-pregnancy@nice.org.uk - Deadline: Tuesday 17th February at 5pm